Clinton Group Inc. lifted its stake in shares of Cigna Corporation (NYSE:CI) by 7.5% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 36,933 shares of the health services provider’s stock after purchasing an additional 2,571 shares during the period. Cigna Corporation comprises about 0.6% of Clinton Group Inc.’s investment portfolio, making the stock its 18th biggest holding. Clinton Group Inc.’s holdings in Cigna Corporation were worth $6,182,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the company. Guardian Life Insurance Co. of America raised its stake in Cigna Corporation by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock worth $145,000 after acquiring an additional 7 shares during the period. Bronfman E.L. Rothschild L.P. raised its stake in Cigna Corporation by 1.1% during the first quarter. Bronfman E.L. Rothschild L.P. now owns 2,112 shares of the health services provider’s stock worth $309,000 after acquiring an additional 22 shares during the period. Wetherby Asset Management Inc. raised its stake in Cigna Corporation by 0.8% during the second quarter. Wetherby Asset Management Inc. now owns 4,192 shares of the health services provider’s stock worth $702,000 after acquiring an additional 33 shares during the period. Cadence Capital Management LLC raised its stake in Cigna Corporation by 0.3% during the second quarter. Cadence Capital Management LLC now owns 9,598 shares of the health services provider’s stock worth $1,607,000 after acquiring an additional 33 shares during the period. Finally, Winslow Evans & Crocker Inc. raised its stake in Cigna Corporation by 1.9% during the second quarter. Winslow Evans & Crocker Inc. now owns 1,814 shares of the health services provider’s stock worth $304,000 after acquiring an additional 34 shares during the period. 87.94% of the stock is currently owned by institutional investors and hedge funds.

Several equities research analysts recently weighed in on CI shares. Credit Suisse Group started coverage on shares of Cigna Corporation in a research note on Monday, June 12th. They set an “outperform” rating and a $185.00 price objective on the stock. Oppenheimer Holdings, Inc. increased their price objective on shares of Cigna Corporation from $174.00 to $185.00 and gave the stock an “outperform” rating in a research note on Thursday, June 15th. Jefferies Group LLC reiterated a “buy” rating and set a $190.00 price objective (down previously from $199.00) on shares of Cigna Corporation in a research note on Friday, August 4th. Morgan Stanley started coverage on shares of Cigna Corporation in a research note on Tuesday, June 6th. They set an “overweight” rating and a $184.00 price objective on the stock. Finally, BidaskClub lowered shares of Cigna Corporation from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Cigna Corporation currently has an average rating of “Buy” and a consensus price target of $187.67.

WARNING: This news story was published by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another site, it was stolen and republished in violation of US and international trademark and copyright law. The legal version of this news story can be viewed at https://www.watchlistnews.com/cigna-corporation-ci-shares-bought-by-clinton-group-inc/1599114.html.

In other Cigna Corporation news, Director William D. Zollars sold 1,232 shares of the business’s stock in a transaction dated Wednesday, September 13th. The shares were sold at an average price of $187.23, for a total value of $230,667.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Chairman Isaiah Harris, Jr. sold 247 shares of the business’s stock in a transaction dated Tuesday, September 12th. The stock was sold at an average price of $185.27, for a total transaction of $45,761.69. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 70,653 shares of company stock worth $12,437,684. Company insiders own 1.30% of the company’s stock.

Cigna Corporation (CI) traded down 0.03% on Friday, hitting $186.94. 1,116,013 shares of the company were exchanged. The stock has a 50 day moving average price of $180.07 and a 200 day moving average price of $165.77. Cigna Corporation has a one year low of $115.03 and a one year high of $188.36. The firm has a market cap of $47.07 billion, a price-to-earnings ratio of 21.57 and a beta of 0.43.

Cigna Corporation (NYSE:CI) last released its quarterly earnings results on Friday, August 4th. The health services provider reported $2.91 EPS for the quarter, beating the Zacks’ consensus estimate of $2.48 by $0.43. The firm had revenue of $10.32 billion for the quarter, compared to analyst estimates of $10.26 billion. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. The company’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period in the previous year, the business earned $1.98 earnings per share. On average, equities research analysts forecast that Cigna Corporation will post $10.03 EPS for the current fiscal year.

About Cigna Corporation

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.